Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Elisabeth Zirwes"'
Autor:
Uwe Grether, Richard H. Foxton, Sabine Gruener, Claudia Korn, Atsushi Kimbara, Anja Osterwald, Elisabeth Zirwes, Sabine Uhles, Janina Thoele, Nadine Colé, Mark Rogers-Evans, Stephan Röver, Matthias Nettekoven, Rainer E. Martin, Jean-Michel Adam, Jürgen Fingerle, Caterina Bissantz, Wolfgang Guba, André Alker, Anna M. Szczesniak, Ross F. Porter, Tom J. Toguri, Franco Revelant, Agnès Poirier, Camille Perret, Lotte Winther, Antonello Caruso, Filomena Fezza, Mauro Maccarrone, Melanie E. M. Kelly, Sascha Fauser, Christoph Ullmer
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionPreclinical studies suggest that cannabinoid receptor type 2 (CB2R) activation has a therapeutic effect in animal models on chronic inflammation and vascular permeability, which are key pathological features of diabetic retinopathy (DR).
Externí odkaz:
https://doaj.org/article/91d1c3e1c6e44284b2f5d719fd280ff1
Autor:
Erick Carreira, Miroslav Kosar, David Sykes, Alexander Viray, Rosa Maria Vitale, Roman Sarott, Rudolf Ganzoni, David Onion, Janelle Tobias, Philipp Leippe, Christoph Ullmer, Elisabeth Zirwes, Wolfgang Guba, Uwe Grether, James Frank, Dmitry Veprintsev
Pharmacological modulation of cannabinoid receptor type 2 (CB2R) holds promise for the treatment of neuroinflammatory disorders, such as Alzheimer’s disease. Despite the importance of CB2R, its expression and downstream signaling are insufficiently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a19f0c420996c76e9ef0d54343b7b00e
https://doi.org/10.26434/chemrxiv-2022-z58fd
https://doi.org/10.26434/chemrxiv-2022-z58fd